Logo

Nyxoah S.A.

NYXH

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.ā€ā€ā€Ž ā€Ž

Healthcare

Medical Instruments & Supplies

2 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$4.79

Price

+4.13%

$0.19

Market Cap

$179.358m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$4.933m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$77.198m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$2.11

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$73.397m

$116.470m

Assets

$43.073m

Liabilities

$19.706m

Debt
Debt to Assets

16.9%

-0.3x

Debt to EBITDA
Free Cash Flow

-$59.339m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in EUR.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases